Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

14-08-2018 | Rheumatoid arthritis | Highlight | News

TNF inhibitors may not increase cancer recurrence risk

Patients with a history of cancer who receive tumor necrosis factor inhibitors for rheumatoid arthritis may not be at increased risk for recurrence, suggests a Swedish population-based study.

20-07-2018 | Granulomatosis with polyangiitis | Editorial | Article

The ongoing evolution of remission maintenance strategies for granulomatosis with polyangiitis

Eric J Gapud and Philip Seo summarize the key milestones in management of severe granulomatosis with polyangiitis, and evaluate the possibility of long-term reduced intensity or drug-free remission for some patients.

31-07-2018 | Pain disorders | View from the clinic | Article

A multidisciplinary approach to managing chronic pain in children

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents.

Latest from across the site

15-08-2018 | Gout | News

Further evidence for the benefits of febuxostat in gout patients with renal impairment

Results of a phase III trial indicate that both the immediate and extended release formulations of febuxostat reduce serum uric acid levels in patients with gout, including those with impaired renal function.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40685

14-08-2018 | Rheumatoid arthritis | Highlight | News

TNF inhibitors may not increase cancer recurrence risk

Patients with a history of cancer who receive tumor necrosis factor inhibitors for rheumatoid arthritis may not be at increased risk for recurrence, suggests a Swedish population-based study.

Source:

Ann Intern Med 2018; doi:10.7326/M17-2812

13-08-2018 | Psoriatic arthritis | News

News in brief

Integrated dermatology–rheumatology clinic may improve PsA management

Collaboration between rheumatologists and dermatologists in a combined clinic may help improve outcomes for patients with psoriatic arthritis, study results suggest.

10-08-2018 | Rheumatoid arthritis | News

Increased early disease activity predicts methotrexate failure in RA

The chances of patients with early rheumatoid arthritis not responding to methotrexate treatment at 6 months increase significantly with increasing disease activity during the first 12 weeks, study findings indicate.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213502

09-08-2018 | Rheumatoid arthritis | News

News in brief

Equivalence of PF-06438179/GP1111 and infliximab demonstrated

Results of a phase III trial indicate that the infliximab biosimilar PF-06438179/GP1111 has similar efficacy, safety, and immunogenicity profiles to its reference product.

08-08-2018 | Systemic lupus erythematosus | News | Article

Early signs of cardiac impairment detected in patients with new-onset SLE

Patients with newly diagnosed systemic lupus erythematosus may experience changes to the cardiac extracellular matrix that are indicative of subclinical cardiac impairment, researchers report.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40671

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits